Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |